BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 3, 2007
View Archived Issues
Modest weight loss seen with pharmacotherapy for obesity/overweight
Read More
Gabapentin shows potential for treatment and prevention of high-altitude headache
Read More
Brivaracetam well tolerated and safe in patients with partial-onset seizures
Read More
Carisbamate reduces frequency of partial-onset seizures
Read More
MediGene and Celltrion sign agreement for anti-L1 monoclonal antibody for cancer
Read More
Inspire initiates phase III clinical trial of epinastine nasal spray for seasonal allergic rhinitis
Read More
Mitsubishi Tanabe reports first half ended September 30, 2007
Read More
Plethora reports positive preliminary results from phase II study of PSD-503
Read More
Nymox reports positive results from clinical study of NX-1207
Read More
Eurand completes gastrointestinal bioavailability study of Zentase for chronic pancreatitis
Read More
Valeant initiates phase IIa trial of retigabine for postherpetic neuralgia
Read More
LifeCycle initiates phase I clinical trial of sirolimus for organ rejection after transplantation
Read More
Regeneron and sanofi-aventis enter collaboration for fully human therapeutic antibodies
Read More
AnGes signs licensing agreement with Meyer for NF-kappaB decoy in the U.S. and Europe
Read More
Roche accepts FDA recommendation to add stronger warning label to Tamiflu
Read More
Celsion reports positive results from animal and stability studies of liposomal docetaxel
Read More
ChemGenex receives shareholder approval to demerge Verva
Read More
Cosmo reports positive results from phase II trial of Rifamycin SV MMX for diarrhea
Read More
Recent Novartis and Almirall patents impart novel therapeutic agents for respiratory disorders
Read More
New analgesic agents described in recent patent literature
Read More
FDA advisory panel recommends approval of Promus/Xience V
Read More
FDA issues approvable letter in response to Mylan's NDA for nebivolol for hypertension
Read More
FDA approves Alcon's Triesence for use in eye surgery
Read More
Chugai and Roche submit MAA to EMEA for Actemra for severe rheumatoid arthritis
Read More
FDA approves Eli Lilly's Cymbalta for major depressive disorder
Read More